Otimizando o uso de drogas anti-EGFR no tratamento de câncer colorretal metastático RAS selvagem
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Otimizando o uso de drogas anti-EGFR no tratamento de câncer colorretal metastático RAS selvagem
-
Narrated by:
-
By:
About this listen
Os médicos oncologistas do Centro de Oncologia e Hematologia Einstein, Dr. Diogo Bugano e Dra. Giselle Moura, ambos especialistas em tumores do trato digestivo, debatem sobre o estudo de origem japonesa, PARADIGM, fase 3, de caráter multicêntrico, que avaliou o tratamento de primeira linha com quimioterapia e Panitumumabe em câncer colorretal metastático RAS selvagem, além de destacar outros estudos que trazem respostas importantes para o tratamento da doença.
What listeners say about Otimizando o uso de drogas anti-EGFR no tratamento de câncer colorretal metastático RAS selvagem
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.